Accuray Incorporated Quick Ratio (ARAY) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Accuray Incorporated  (NASDAQ: ARAY)

Accuray Incorporated's Quick Ratio

ARAY's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Accuray Incorporated's Cash & cash equivalent grew by 4.01 % in the Q1 2026 sequentially, while Current Liabilities decreased, this led to improvement in Accuray Incorporated's Quick Ratio to 0.25, Quick Ratio remained below Accuray Incorporated average.

Within Medical Equipment & Supplies industry 169 other companies have achieved higher Quick Ratio than Accuray Incorporated in first quarter 2026. While Quick Ratio total ranking has improved so far during the Q1 2026 to 3510, from total ranking in the fourth quarter 2026 at 4223.

Explain Quick Ratio?
How much Cash & cash equivalents ARAY´s has?
What are ARAY´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ARAY/financial-strength
https://api.csimarket.com/api/v1/companies/ARAY/fundamentals
https://api.csimarket.com/api/v1/companies/ARAY/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
ARAY Quick Ratio (Sep 30 2026)
Q1
(Jun 30 2026)
Q4
(Mar 31 2026)
Q3
(Dec 31 2025)
Q2
(Sep 30 2025)
Q1
Y / Y Current Liabilities Change -12.59 %
Y / Y Cash & cash equivalent Change -33.29 %
Quick Ratio MRQ 0.25
ARAY's Total Ranking # 3510
Seq. Current Liabilities Change -11.13 %
Seq. Cash & cash equivalent Change 4.01 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 170
Healthcare Sector # 808
Overall Market # 3229


Quick Ratio Statistics
High Average Low
1.56 0.61 0.18
(Jun 30 2015)   (Mar 31 2026)




Financial Statements
Accuray Incorporated's Current Liabilities $ 170 Millions Visit ARAY's Balance sheet
Accuray Incorporated's Cash & cash equivalent $ 42 Millions Visit ARAY's Balance sheet
Source of ARAY's Sales Visit ARAY's Sales by Geography


Cumulative Accuray Incorporated's Quick Ratio

ARAY's Quick Ratio for the trailling 12 Months

ARAY Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -3.19 %
Y / Y Cash & cash equivalent TTM Growth -37.88 %
Quick Ratio TTM 0.21
Total Ranking TTM # 4139
Seq. Current Liabilities TTM Growth -3.1 %
Seq. Cash & cash equivalent TTM Growth -11.5 %


On the trailing twelve months basis In spite of the year on year decrease in ARAY's Current Liabilities to $170.11 millions, cumulative Quick Ratio to 0.21 below the ARAY average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 206 other companies have achieved higher Quick Ratio than Accuray Incorporated. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2026 from 4093 to 4139.

Explain Quick Ratio?
How much Cash & cash equivalents ARAY´s has?
What are ARAY´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 207
Healthcare Sector # 916
Within the Market # 4139


trailing twelve months Quick Ratio Statistics
High Average Low
1.1 0.6 0.26
(Dec 31 2013)   (Jun 30 2026)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Sintx Technologies Inc   0.67 $ 2.005  Millions$ 3.004  Millions
Privia Health Group Inc   0.66 $ 446.283  Millions$ 674.358  Millions
Lensar Inc   0.64 $ 12.622  Millions$ 19.811  Millions
Orthofix Medical Inc   0.62 $ 86.322  Millions$ 138.385  Millions
Carlisle Companies Incorporated  0.62 $ 546.700  Millions$ 880.300  Millions
Align Technology inc   0.57 $ 1,144.931  Millions$ 2,002.010  Millions
Angiodynamics Inc   0.57 $ 33.973  Millions$ 59.689  Millions
Co diagnostics Inc   0.57 $ 1.430  Millions$ 2.512  Millions
Baxter International Inc   0.52 $ 1,976.000  Millions$ 3,809.000  Millions
Infusystem Holdings Inc  0.51 $ 9.108  Millions$ 17.873  Millions
Stryker Corp  0.50 $ 3,271.000  Millions$ 6,500.000  Millions
Msa Safety Inc  0.50 $ 187.248  Millions$ 373.698  Millions
Teleflex Incorporated  0.50 $ 454.065  Millions$ 917.102  Millions
Sonoma Pharmaceuticals Inc   0.46 $ 4.609  Millions$ 9.944  Millions
P3 Health Partners Inc   0.46 $ 43.900  Millions$ 95.593  Millions
Avita Medical Inc   0.46 $ 10.500  Millions$ 23.037  Millions
Alphatec Holdings Inc   0.44 $ 79.936  Millions$ 180.767  Millions
Steris Plc  0.44 $ 531.100  Millions$ 1,207.800  Millions
Sanuwave Health Inc   0.40 $ 6.569  Millions$ 16.394  Millions
Novocure Limited  0.38 $ 102.738  Millions$ 270.659  Millions
Cadre Holdings inc   0.36 $ 63.916  Millions$ 178.051  Millions
U S Physical Therapy Inc  0.35 $ 38.225  Millions$ 109.218  Millions
Tela Bio Inc   0.31 $ 22.664  Millions$ 73.706  Millions
Tandem Diabetes Care Inc   0.28 $ 72.840  Millions$ 256.075  Millions
Ufp Technologies Inc   0.27 $ 20.625  Millions$ 77.359  Millions
Docgo Inc   0.26 $ 20.569  Millions$ 79.655  Millions
Bausch and Lomb Corp  0.25 $ 513.000  Millions$ 2,019.000  Millions
Accuray Incorporated  0.25 $ 42.254  Millions$ 170.106  Millions
Cerus Corporation  0.20 $ 16.350  Millions$ 80.006  Millions
Bioventus Inc   0.19 $ 30.709  Millions$ 159.282  Millions

Date modified: 2026-11-09T15:20:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.